Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06131957

Root Caries Prevention Using Fluoride Varnish Fortified With SBGC

Root Caries Prevention Using Fluoride Varnish Fortified With Strontium-doped Bioactive Glass Ceramic: a Randomized Double-blind Controlled Clinical Trial

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
540 (estimated)
Sponsor
The University of Hong Kong · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

The goal of this 36-month double-blind randomized controlled trial is to compare the effects of 5% sodium fluoride varnish (22,600 ppm fluoride) with or without Strontium-doped bioactive glass (SBGC) on root caries development in community-dwelling older adults.

Detailed description

This 36-month, double-blind, two-arm randomized controlled trial is aimed to compare the effects of 5% sodium fluoride varnish (22,600 ppm fluoride) with or without Strontium-doped bioactive glass (SBGC) on root caries development in community-dwelling older adults. Participants will be divided in to two groups, The main question it aims to answer is: Is fluoride varnish with SBGC more effective than that without SBGC on prevention root caries in community-dwelling older adults? Participants will be divided into two groups, experimental group and controlled group after randomization. Subjects in the experimental group will receive fluoride varnish with SBGC quarterly, and subjects in the controlled group will receive fluoride varnish without SBGC quarterly. It is hypothesized that community-dwelling older adults who receive quarterly fluoride varnish applications containing SBGC will develop fewer root caries.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTFluoride varnish with SBGCThe Fluoride varnish (containing 5% NaF, Duraphat®, Colgate-Palmolive Company, NY, USA) mixed with 7.5% SBGC (Dencare (Chongqing) Oral Care Co., Ltd).
DRUGFluoride varnishThe Fluoride varnish (containing 5% NaF, Duraphat®, Colgate-Palmolive Company, NY, USA)

Timeline

Start date
2024-01-15
Primary completion
2027-01-01
Completion
2027-12-01
First posted
2023-11-15
Last updated
2025-06-10

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT06131957. Inclusion in this directory is not an endorsement.